SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,878.00    130.00 (4.73%)
Bid:
2,846.00
Ask:
2,862.00
Spread: 16.00 (0.562%)
Market Cap: £1.59b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

Interim Management Statement

12 Jul 2012 07:00

RNS Number : 4716H
Oxford Instruments PLC
12 July 2012
Β 

ο»Ώ

Oxford Instruments plc

Interim Management Statement

Β 

12 July 2012

Β 

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today issues an Interim Management Statement which covers the period from 1 April 2012 to date.

The Group has made an encouraging start to the year with orders, sales and profits all ahead of the same period last year on both an organic and reported basis.

Save as described in this statement, there has been no significant change in the financial position of the Group in the period.

Our markets remain strong despite continued economic uncertainty, particularly in Europe. A healthy pipeline of new product introductions is in place and we are investing across the business to increase efficiency, strengthen our market positions and drive further profitable growth. Accordingly, the Board anticipates that Oxford Instruments will continue to make good progress in line with its expectations for the financial year and consistent with its 14 cubed objectives.

Β 

Enquiries:

Β 

Oxford Instruments plc

Jonathan Flint, Chief Executive

Tel: 01865 393200

Kevin Boyd, Group Finance Director

Β 

MHP

Rachel Hirst / Ian Payne

Tel: 020 3128 8100

Β 

This Interim Management Statement contains certain forward-looking statements which have been made by the Directors in good faith using information available up until the date they approved the Statement. Forward-looking statements should be regarded with caution as by their nature such statements involve risk and uncertainties relating to events and circumstances that may occur in the future. Actual results may differ from those expressed in such statements, depending on the outcome of these uncertain future events.

Β 

Β 

Notes to Editors

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. It provides solutions needed to advance fundamental physics research and its transfer into commercial nanotechnology applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 50 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion.Β 

The first technology business to be spun out fromΒ OxfordΒ UniversityΒ over fifty years ago, Oxford Instruments is now a global company with over 1900 staff worldwide and a listing on the London Stock Exchange (OXIG). Its objective is toΒ be the leading provider of new generation tools and systems for the research and industrial sectors.

This involves the combination of core technologies in areas such as low temperature and high magnetic field environments, NuclearΒ Magnetic Resonance, X-ray electron and optical based metrology, and advanced growth, deposition and etching.Β Oxford Instruments'Β products, expertise, and ideas address global issues such as energy, environment, security and health.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSBUGDRDXBBGDB
Date   Source Headline
9th Jul 20132:16 pmPRNHolding(s) in Company
2nd Jul 20132:11 pmPRNBlocklisting - Interim Review
1st Jul 201310:42 amPRNDirector/PDMR Shareholding
26th Jun 20132:57 pmPRNHolding(s) in Company
17th Jun 201310:45 amPRNHolding(s) in Company
12th Jun 20132:53 pmPRNDirector/PDMR Shareholding
11th Jun 20137:00 amRNSFinal Results
11th Jun 20137:00 amRNSAppointment of Non-Executive Director
3rd Jun 20133:44 pmPRNTotal Voting Rights
30th May 201311:34 amPRNDirector/PDMR Shareholding
7th May 201310:08 amPRNTotal Voting Rights
30th Apr 201311:22 amPRNDirector/PDMR Shareholding
29th Apr 20138:53 amPRNHolding(s) in Company
25th Apr 20137:57 amPRNDirector Declaration
23rd Apr 20132:28 pmPRNDirector/PDMR Shareholding
22nd Apr 20131:54 pmPRNAnnual Information Update
19th Apr 201312:01 pmPRNHolding(s) in Company
9th Apr 20137:00 amRNSPre-close Trading Update
2nd Apr 201311:07 amPRNTotal Voting Rights
2nd Apr 201310:26 amPRNDirector/PDMR Shareholding
4th Mar 20132:45 pmPRNTotal Voting Rights
1st Mar 201311:36 amPRNDirector/PDMR Shareholding
13th Feb 20137:00 amRNSInterim Management Statement
13th Feb 20137:00 amRNSCapital Markets Day
7th Feb 20139:33 amPRNHolding(s) in Company
6th Feb 20138:58 amPRNHolding(s) in Company
4th Feb 201311:37 amPRNTotal Voting Rights
4th Feb 20139:26 amPRNHolding(s) in Company
30th Jan 20139:35 amPRNDirector/PDMR Shareholding
8th Jan 201311:46 amPRNHolding(s) in Company
8th Jan 201310:25 amPRNDirectorate Change
3rd Jan 201310:40 amPRNTotal Voting Rights
3rd Jan 201310:33 amPRNBlocklisting - Interim Review
2nd Jan 201312:47 pmPRNDirector/PDMR Shareholding
2nd Jan 201310:20 amPRNHolding(s) in Company
21st Dec 201210:15 amPRNHolding(s) in Company
19th Dec 20121:31 pmPRNHolding(s) in Company
19th Dec 20121:15 pmPRNDirector/PDMR Shareholding
19th Dec 20121:07 pmPRNDirector/PDMR Shareholding
19th Dec 201210:35 amRNSCompletion of Acquisition
17th Dec 20121:46 pmPRNDirector/PDMR Shareholding
17th Dec 20127:00 amRNSAcquisition
3rd Dec 20129:19 amPRNDirector/PDMR Shareholding
20th Nov 201210:56 amPRNHolding(s) in Company
16th Nov 20128:54 amPRNHolding(s) in Company
13th Nov 20127:00 amRNSHalf Yearly Report
30th Oct 201211:56 amPRNDirector/PDMR Shareholding
29th Oct 201211:11 amPRNHolding(s) in Company
23rd Oct 20123:37 pmPRNHolding(s) in Company
22nd Oct 20129:17 amPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.